Ozempic, Wegovy, Mounjaro and Zepbound Gastroparesis: Risk and Recovery
Can Ozempic or Zepbound cause gastroparesis (stomach paralysis)? How GLP-1 drugs slow the stomach, what labels and studies show, symptoms, recovery and anaesthesia risk.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Gastroparesis means the stomach empties too slowly without any blockage, causing nausea, vomiting, early fullness, bloating and pain. Ozempic, Wegovy, Mounjaro and Zepbound all slow stomach emptying as part of how they work (Jalleh 2024 review). In a small number of people this goes further and causes severe symptoms. All four labels say the drugs are not recommended in severe gastroparesis, and postmarketing reports include ileus and intestinal obstruction. In published cases, symptoms resolved after the drug was stopped. Not medical advice. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance. Facts checked October 24, 2026.
What the labels say
The US labels (Ozempic, Wegovy, Mounjaro, Zepbound) each state that the drug "delays gastric emptying", that use has been linked to gastrointestinal reactions that are sometimes severe, and that it "is not recommended in patients with severe gastroparesis". Postmarketing reports list ileus, intestinal obstruction and severe constipation including faecal impaction. The patient information asks people to tell their prescriber if they have "slowed emptying of your stomach (gastroparesis)". The Canadian Ozempic monograph lists delayed gastric emptying, intestinal obstruction and ileus in postmarketing reports and warns that people with gastroparesis may have more serious stomach side effects; the Wegovy monograph says the same.
How common is it?
Trials did not measure gastroparesis well, so most numbers come from insurance-claims studies. They show a higher relative risk but a low absolute one.
| Study | Who | Finding |
|---|---|---|
| Alkabbani 2026 | 313,342 matched pairs of US adults with type 2 diabetes (lead author at the University of Waterloo) | Severe constipation, gastroparesis or obstruction: 1.02 vs 0.75 per 100 person-years on SGLT2 inhibitors (HR 1.37). Absolute risk 1% or less |
| Sodhi 2023 | People without diabetes using semaglutide or liraglutide for weight loss (Vancouver researchers) | Gastroparesis HR 3.67 (95% CI 1.15 to 11.9) vs bupropion-naltrexone; small numbers |
| Crisafulli 2026 | Three matched cohorts of adults with type 2 diabetes, up to 65,238 pairs each | Semaglutide, tirzepatide and dulaglutide had similar gastrointestinal safety |
| Chiang 2025 | 55 randomised trials, 106,395 people | More gallstones and reflux; little or no effect on other gut events in trials |
Symptoms to watch
- —Nausea and vomiting that keep going, especially vomiting food eaten hours earlier.
- —Feeling full after a few bites, bloating or upper stomach pain.
- —Being unable to keep fluids down, or signs of dehydration such as dizziness and little urine.
- —A swollen, hard belly, severe constipation or no bowel movements, which can mean obstruction or ileus and need urgent care.
Does it go away after stopping?
In most published cases, yes. A 2026 systematic review of 13 people with gastroparesis linked to GLP-1 drugs found symptoms started anywhere from hours to months after starting, often after a dose increase or restarting, and that stopping the drug led to symptom resolution in every reported patient (Olubodun 2026). That is a small set of case reports, not a rate. Some users describe much slower recovery; in our archive #603 describes repeated hospital visits for vomiting, a gastroparesis diagnosis, and still vomiting months after stopping semaglutide.
How doctors diagnose and treat it
A 2026 JAMA review (Camilleri 2026) notes that medicines cause about 12% of gastroparesis cases in a large US study, after diabetes and surgery. Diagnosis needs symptoms plus a gastric emptying scan (or an approved breath test) after a scope or scan has ruled out a blockage. Treatment starts with stopping drugs that slow the stomach, including GLP-1 drugs, opioids and cannabis, then a small-particle diet low in fat and fibre and anti-nausea medicine. Any change to a prescription is the prescriber's decision.
Anaesthesia, endoscopy and food left in the stomach
Slower emptying matters before sedation. The labels report rare cases of pulmonary aspiration (stomach contents entering the lungs) during anaesthesia in people on GLP-1 drugs who had followed fasting rules. In a 2026 Belgian study, ultrasound found a "full stomach" in 49% of fasted surgical patients on semaglutide vs 18% of matched controls (Vlaeminck 2026), and a study in the Canadian Journal of Anesthesia found visible stomach contents at endoscopy in 19% of procedures on GLP-1 drugs vs 5% in controls (Wu 2024). Tell the surgical or endoscopy team you take one of these drugs.
What users report here
Gastroparesis is named in one live confession (checked October 24, 2026): #603 lost a large amount of weight in year one on semaglutide, then spent year two in and out of hospital for vomiting. More common, milder stomach complaints are on Ozempic nausea, Ozempic constipation and sulfur burps. In Canada, see Ozempic side effects in Canada. Stories, not rates.
Related topics
data reports:
related peptides:
in Canada:
community guides:
More confessions from the archive
Community Q&A
- Can Ozempic cause gastroparesis?
- Ozempic slows stomach emptying, and severe cases resembling gastroparesis have been reported. Labels say it is not recommended in people who already have severe gastroparesis.
- Does Zepbound or Mounjaro cause gastroparesis?
- Tirzepatide also delays gastric emptying, and both labels say it is not recommended in severe gastroparesis. A 2026 study found similar gut safety for tirzepatide and semaglutide.
- Is Ozempic gastroparesis permanent?
- In published case reports, symptoms resolved after stopping the drug. Recovery time varies, and some people report symptoms lasting months.
- How common is gastroparesis on GLP-1 drugs?
- Uncommon. A 2026 study of over 300,000 pairs found severe motility events in about 1 per 100 person-years on GLP-1 drugs vs 0.75 on SGLT2 inhibitors.
- What are the symptoms of stomach paralysis on Ozempic?
- Persistent nausea and vomiting, early fullness, bloating and upper stomach pain. Severe constipation or a swollen belly can mean obstruction and needs urgent care.
- Should I tell my surgeon I take Ozempic?
- Yes. Labels warn of rare aspiration during anaesthesia because food can stay in the stomach despite fasting.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Last reviewed November 11, 2026. Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.